RxDoctor Payments Data

Matthew Sideman, MD

Vascular Surgery · San Antonio, TXNPI 1386614774

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $8,479 of the $11,123 with a category attached, or 76.2%. It is spread thinly across 38 manufacturers, the largest accounting for just 22.4% — the pattern of someone who eats at a lot of different presentations.

$11,123in general payments, 2019–2025

Across 204 payments — averaging $54.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • W. L. Gore & Associates, Inc.$2K
  • Reflow Medical Inc$2K
  • Medtronic$1K
  • Bard Peripheral Vascular, Inc.$959
  • Cook Medical LLC$851
  • Endologix LLC$473
  • plus $3K from 32 others
$30,906in research payments, 2019–2025

Across 8 payments — averaging $3863.23 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Shape Memory Medical Inc.$27K
  • W. L. Gore & Associates, Inc.$4K

What the payments were for

  • Travel & lodging$2,64424%
  • Food & beverage$8,47976%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,123 in reported general payments places this provider in the 60th percentile of 347 vascular surgery providers in Texas.

See all vascular surgery providers in Texas

Medicare billing

Part B allowed, 2024
$162,002
Medicare patients
339
Services billed
832

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate67$652
Cilostazol19$275

Paid to pharmacies, not to this prescriber.

Other vascular surgery in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →